105 Maxess Road
Suite 124
Melville, NY 11747
United States
631-574-4436
https://sharpstechnology.com
Sektor(en): Healthcare
Branche: Medical Instruments & Supplies
Vollzeitmitarbeiter: 57
Name | Titel | Zahlen | Ausgeübt | Geburtsjahr |
---|---|---|---|---|
Mr. Robert M. Hayes | CEO & Director | 516,67k | N/A | 1968 |
Mr. Andrew R. Crescenzo CPA | Chief Financial Officer | 236,23k | N/A | 1956 |
Mr. Ben Scheu | Senior Director of Sales | N/A | N/A | N/A |
Dr. Steven Hertz M.D. | Chief Medical Officer | N/A | N/A | 1962 |
Mr. Adam S. Holdsworth | Managing Director | N/A | N/A | N/A |
Sharps Technology, Inc., a medical device company, engages in the design, research and development, manufacturing, and commercialization of safety syringe products in the United States. The company provides safety syringe products comprising Securgard, Sologard, and Sharps Provensa that are ultra-low waste syringes for passive, and safety and reuse prevention features, as well as develops prefillable syringe systems. Sharps Technology, Inc. was incorporated in 2017 and is based in Melville, New York.
Sharps Technology, Inc.s ISS Governance QualityScore, Stand N/A, lautet N/A. Die grundlegenden Scores sind Audit: N/A, Vorstand: N/A, Shareholderrechte: N/A, Kompensation: N/A.